STONKWHISPER
← Back to Intel
Insider ActivityRXRX

Khan Najat, CEO and President, Director at RECURSION PHARMACEUTICALS, INC., sold $84K of RXRX

Updated Jun 19, 2026
Khan Najat CEO and President, Director
RECURSION PHARMACEUTICALS, INC. · $RXRX
$84K Total Value
23,588 Shares Traded
$3.5806 Price / Share
2,175,796 Shares Owned After
2026-06-05 Filing Date

Transaction Details

InsiderKhan Najat
TitleCEO and President, Director
CompanyRECURSION PHARMACEUTICALS, INC.
TickerRXRX
Transaction TypeSale
Transaction Date2026-06-05
Shares Traded23,588
Price Per Share$3.5806
Total Value$84K
Filed Date2026-06-05
Accession Number0002020969-26-000004

Ownership Context

Shares Owned After Transaction2,175,796
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002020969-26-000004

Other Insider Trades — RXRX

Other Trades by Khan Najat

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for RXRX — RECURSION PHARMACEUTICALS, INC. →

Whisper Score — RXRX

33.41
Murmurs
Current Whisper Score

See full analysis for RXRX →

Track RXRX insider activity in real time on The Wire →

Get alerts when Khan Najat files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:03 UTC

Want real-time data? Access The Wire for live sentiment tracking.